HomeInsightsPE

Concord Biotech Ltd PE Ratio

Concord Biotech Ltd PE Ratio

stocks purchased

₹ 6.0 Cr

Volume transacted

stocks purchased

26.7 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PE

75.4

Last updated: 19 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of Concord Biotech Ltd is 75.4 as of 19 Sep 15:30 PM.
  • The P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2020 to 51.7 on March 2024 . This represents a CAGR of 0.00% over 1 years. .
  • The Latest Trading Price of Concord Biotech Ltd is ₹ 2258 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

No data available

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PRICE

2258.2

72.85 (3.33%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20242258.2
18 Sep 20242185.35
17 Sep 20242080.2
16 Sep 20242085.6
13 Sep 20242074.35
12 Sep 20242002.4
11 Sep 20241941.05
10 Sep 20241902.7
09 Sep 20241854.45
06 Sep 20241835.45

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Concord Biotech Ltd7523,624
Sun Pharmaceuticals Industries Ltd424,43,025
Divis Laboratories Ltd861,44,299
Cipla Ltd291,32,316
Torrent Pharmaceuticals Ltd671,13,396
Dr Reddys Laboratories Ltd191,08,579

Key Valuation Metric of Concord Biotech Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payout of Concord Biotech Ltd

No data available

* All values are in %

About Concord Biotech Ltd

  • Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
  • Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC.
  • The Company is an India-based biopharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immuno-suppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
  • Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

Concord Biotech Ltd News Hub

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

29 Aug 202414:30

News

Concord Biotech schedules board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2...

Read more

31 Jul 202414:25

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

News

Concord Biotech declare Quarterly Result

Concord Biotech will hold a meeting of the Board of Directors of the Company on 23 May 202...

Read more

16 May 202412:02

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Concord Biotech Ltd

What is the current PE Ratio of Concord Biotech Ltd?

The Current PE Ratio of Concord Biotech Ltd is 75.42 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Concord Biotech Ltd last year?

The PE Ratio of Concord Biotech Ltd was 0.0 last year, now the PE ratio is 75.42, showing a year-on-year growth of -%.

What does the PE Ratio of Concord Biotech Ltd indicate about its stock?

The PE Ratio of Concord Biotech Ltd is 75.42. This ratio indicates that investors are willing to pay 75.42 times the earnings per share for each share of Concord Biotech Ltd.

What is the PE Ratio Growth of Concord Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Concord Biotech Ltd grew by -% whereas, the EPS ratio grew by -37.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*